Baillie Gifford & Co. has recently announced that it has increased stake in Exscientia plc (NASDAQ:EXAI) by 6.58%. After grabbing 5.24 million shares, the institutional investor is now in possession of 0.32 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.26% having worth around $26.89 million. Moreover, Laurion Capital Management LP increased its share by 0.77 million to have a control over 3.13 million shares.
Exscientia plc (EXAI) concluded trading on 05/25/23 at a closing price of $7.87, with 1.31 million shares of worth about $10.3 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 35.22% during that period and on Thursday the price saw a loss of about -2.48%. Currently the company’s common shares owned by public are about 122.96M shares, out of which, 102.90M shares are available for trading.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 4 analysts are covering the EXAI stock and their offered price forecasts bring an average price target of $14.75. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $17.00 and could fall to a lowest price of $12.00. The stock’s current price level is 46.64% above of average price target set by the analysts, while a rise to estimated low would result in gain of 34.42% for the stock. However, touching the estimated high of $17.00 would mean a gain of 53.71% for the stock.
BlackRock Global Allocation Fund, BlackRock Global Funds – Global A, and Pictet – Biotech are the top 3 mutual funds which are holding stakes in Exscientia plc BlackRock Global Allocation Fund is currently holding 1.11 million shares of worth totaling $5.7 million. The company recently came selling -0.82 million shares which brought its stake up to 0.90% of the company’s outstanding shares. BlackRock Global Funds – Global A sold -0.27 million shares, after which its hold over company’s outstanding shares shrunk to 0.75%, leaving 0.93 million shares with the mutual fund that have a worth of about $4.75 million. Pictet – Biotech, after buying 0.88 million shares, have now control over 0.72% of the stake in the company. It holds 40781.0 shares of worth $4.54 million.
Exscientia plc (NASDAQ: EXAI) started trading at $8.30, above $0.23 from concluding price of the previous day. However, the stock later moved at a day high price of 8.60, or with a loss of -2.48%. Stock saw a price change of 39.05% in past 5 days and over the past one month there was a price change of 54.31%. Year-to-date (YTD), EXAI shares are showing a performance of 47.65% which decreased to -19.78% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.09 but also hit the highest price of $16.45 during that period. The average intraday trading volume for Exscientia plc shares is 308.84K. The stock is currently trading 39.01% above its 20-day simple moving average (SMA20), while that difference is up 39.48% for SMA50 and it goes to 13.67% higher than SMA200.
Baillie Gifford & Co. acquired 5.24 million shares of Exscientia plc having value of about $26.89 million. Data submitted at the U.S SEC by Baillie Gifford & Co. revealed that the firm now holds 0.32 million shares in the company valued at close to $2548187.95, or have control over 6.58% stake in the company. Exscientia plc (NASDAQ: EXAI) currently have 122.96M outstanding shares and institutions hold larger chunk of about 23.00% of that. Holding of mutual funds in the company is about 15.10% while other institutional holders and individual stake holders have control over 5.42% and — of the stake respectively.
The stock has a current market capitalization of $906.86M. It has posted earnings per share of -$1.02 in the same period. It has Quick Ratio of 7.50 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EXAI, volatility over the week remained 18.19% while standing at 9.65% over the month.
Analysts are in expectations that Exscientia plc (EXAI) stock would likely to be making an EPS of -$0.43 in the current quarter, while forecast for next quarter EPS is -$0.43 and it is -$1.86 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.43 which is -$0.43 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.41 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -45.30% while it is estimated to decrease by -9.40% in next year.
Analysts at 4 brokerage firms have issued recommendations for the Exscientia plc (EXAI)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 4 Wall Street analysts, 2 recommended a “Buy” rating, while 1 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Leave a Reply